all the information, none of the junk | biotech • healthcare • life sciences

Impel NeuroPharma Names Jon Congleton President and CEO

Xconomy Seattle — 

Jon Congleton has been named president and CEO of Seattle-based Impel NeuroPharma. Congleton was most recently president and CEO of Nivalis Therapeutics in Boulder, CO. Impel is developing intranasal drug treatments for central nervous system disorders.